Lombard Medical Inc. logo

Lombard Medical Inc. (EVARF)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
2.79K Market Cap
- P/E Ratio
- Div Yield
125 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track EVARF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

EVARF closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, EVARF stock gained 0%.
EVARF is not paying dividends to its shareholders.
The last earnings report, released on May 09, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Lombard Medical Inc. has completed 1 stock splits, with the recent split occurring on Mar 28, 2012.
The company's stock is traded on one exchange.

EVARF Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.38
-1.8088%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Lombard Medical Inc. (EVARF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Lombard Medical Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is EVARF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.79K.

Has Lombard Medical Inc. ever had a stock split?

Lombard Medical Inc. had 1 splits and the recent split was on Mar 28, 2012.

Lombard Medical Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Kurt Lemvigh CEO
OTC PINK Exchange
G55598109 CUSIP
GB Country
113 Employees
- Last Dividend
28 Mar 2012 Last Split
13 Dec 2005 IPO Date

Overview

Lombard Medical, Inc. is a pioneering medical technology company dedicated to developing, manufacturing, and distributing endovascular stent-grafts used in the repair of aortic aneurysms. The company operates globally, with a significant presence in the United States, the United Kingdom, Germany, Japan, and other international markets. Since its inception in 2000, Lombard Medical has focused on addressing the complex challenges associated with aortic aneurysm repairs, primarily through its flagship product, Aorfix. The company's commitment to innovation is evident in its comprehensive product line designed for various aneurysm anatomies and complexities. Headquartered in Didcot, the United Kingdom, Lombard Medical, Inc. leverages a combination of direct sales force and distributors to make its cutting-edge solutions accessible to state-or-government-owned hospitals worldwide.

Products and Services

  • Aorfix:
  • A pivotal endovascular stent-graft designed for the treatment of abdominal aortic aneurysms (AAAs), particularly those with angulations at the neck of the aneurysm up to 90 degrees. Aorfix's unique flexibility offers a versatile and effective solution for a wide range of AAA geometries, contributing to improved patient outcomes.

  • Altura:
  • An innovative endovascular stent graft system specifically developed for the treatment of standard AAA anatomies. The Altura system's design simplifies the procedure, allowing for a minimally invasive approach that significantly reduces the recovery time and risks associated with traditional open surgery.

  • Aorflex Delivery System:
  • This delivery system is engineered to facilitate the precise placement of Aorfix within the abdominal aorta. The Aorflex technology enhances the surgeon's ability to navigate challenging anatomical structures, ensuring optimal alignment and securement of the stent-graft.

  • IntelliFlex LP Delivery System:
  • A state-of-the-art delivery system that extends the capabilities of Aorfix deployment. The IntelliFlex LP Delivery System introduces enhanced precision and control during the stent-graft placement, reinforcing Lombard Medical's commitment to technological advancement and surgical excellence.

Contact Information

Address: 4 Trident Park
Phone: 44 12 3575 0800